Home LiteratureArticle Details
PMID: 11457890 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Fas ligand triggers pulmonary silicosis.

The Journal of experimental medicine ·Vol. 194 ·No. 2 ·2001-07-16 ·Pages 155-64

Borges VM, Falcão H, Leite-Júnior JH, Alvim L, Teixeira GP, Russo M, Nóbrega AF, Lopes MF, Rocco PM, Davidson WF, Linden R, Yagita H, Zin WA, DosReis GA

Abstract

We investigated the role of Fas ligand in murine silicosis. Wild-type mice instilled with silica developed severe pulmonary inflammation, with local production of tumor necrosis factor (TNF)-alpha, and interstitial neutrophil and macrophage infiltration in the lungs. Strikingly, Fas ligand-deficient generalized lymphoproliferative disease mutant (gld) mice did not develop silicosis. The gld mice had markedly reduced neutrophil extravasation into bronchoalveolar space, and did not show increased TNF-alpha production, nor pulmonary inflammation. Bone marrow chimeras and local adoptive transfer demonstrated that wild-type, but not Fas ligand-deficient lung macrophages recruit neutrophils and initiate silicosis. Silica induced Fas ligand expression in lung macrophages in vitro and in vivo, and promoted Fas ligand-dependent macrophage apoptosis. Administration of neutralizing anti-Fas ligand antibody in vivo blocked induction of silicosis. Thus, Fas ligand plays a central role in induction of pulmonary silicosis.

MeSH Terms
Adoptive Transfer Animals Apoptosis Disease Models, Animal Fas Ligand Protein Female In Vitro Techniques Lymphoproliferative Disorders/genetics,immunology,pathology Macrophages/pathology Male Membrane Glycoproteins/deficiency,physiology Mice Mice, Inbred BALB C Mice, Mutant Strains Neutrophils/pathology Radiation Chimera Silicon Dioxide/toxicity Silicosis/etiology,genetics,pathology Tumor Necrosis Factor-alpha/biosynthesis
Chemicals
Fas Ligand Protein Fasl protein, mouse Membrane Glycoproteins Tumor Necrosis Factor-alpha Silicon Dioxide
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Borges V M
Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21944-970, Rio de Janeiro, Brazil.
Falcão H
Leite-Júnior J H
Alvim L
Teixeira G P
Russo M
Nóbrega A F
Lopes M F
Rocco P M
Davidson W F
Linden R
Yagita H
Zin W A
DosReis G A
References (38)
38 references, click to expand
  1. Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages.
    J Immunol. 2000 Aug 15;165(4):2124-33 PMID: 10925298
  2. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.
    Nat Med. 2000 May;6(5):493-5 PMID: 10802692
  3. CD95's deadly mission in the immune system.
    Nature. 2000 Oct 12;407(6805):789-95 PMID: 11048730
  4. Lung tissue mechanics and extracellular matrix composition in a murine model of silicosis.
    J Appl Physiol (1985). 2001 Apr;90(4):1400-6 PMID: 11247940
  5. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice.
    Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):762-9 PMID: 11254536
  6. Experimental silicosis. II. Long-term effects of intratracheally instilled quartz on collagen metabolism and morphologic characteristics of rat lungs.
    Am J Pathol. 1983 Jan;110(1):30-40 PMID: 6295174
  7. Two-sidearm tracheal cannula for respiratory airflow measurements in small animals.
    J Appl Physiol Respir Environ Exerc Physiol. 1983 Jul;55(1 Pt 1):250-3 PMID: 6885578
  8. Kinetics of inflammatory and fibrotic pulmonary changes in a murine model of silicosis.
    J Lab Clin Med. 1985 May;105(5):547-53 PMID: 2985721
  9. A theoretical analysis of interrupter technique for measuring respiratory mechanics.
    J Appl Physiol (1985). 1988 May;64(5):2204-14 PMID: 3391919
  10. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action?
    Free Radic Biol Med. 1989;7(6):645-51 PMID: 2695408
  11. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.
    Nature. 1990 Mar 15;344(6263):245-7 PMID: 2156165
  12. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
    Cell. 1994 Mar 25;76(6):969-76 PMID: 7511063
  13. Fas ligand-induced apoptosis as a mechanism of immune privilege.
    Science. 1995 Nov 17;270(5239):1189-92 PMID: 7502042
  14. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica.
    J Immunol. 1996 Feb 15;156(4):1540-8 PMID: 8568258
  15. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation.
    J Immunol Methods. 1996 Oct 30;198(1):1-14 PMID: 8914592
  16. T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice.
    Thorax. 1996 Oct;51(10):1036-42 PMID: 8977606
  17. Antitumor effect of locally produced CD95 ligand.
    Nat Med. 1997 Feb;3(2):165-70 PMID: 9018234
  18. Polymorphism of murine Fas ligand that affects the biological activity.
    Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3914-9 PMID: 9108079
  19. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction.
    Nat Med. 1997 Jul;3(7):738-43 PMID: 9212099
  20. Involvement of the ICE family of proteases in silica-induced apoptosis in human alveolar macrophages.
    Am J Physiol. 1997 Oct;273(4 Pt 1):L760-7 PMID: 9357850
  21. Gene transfer of Fas ligand induces tumor regression in vivo.
    Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13862-7 PMID: 9391118
  22. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression.
    J Biol Chem. 1998 Apr 3;273(14):8048-55 PMID: 9525905
  23. Silicosis in mice: effects of dose, time, and genetic strain.
    J Environ Pathol Toxicol Oncol. 1998;17(2):81-97 PMID: 9546745
  24. Mechanisms in the pathogenesis of asbestosis and silicosis.
    Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1666-80 PMID: 9603153
  25. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis.
    J Immunol. 1998 Jun 1;160(11):5448-54 PMID: 9605147
  26. Chemotactic activity of soluble Fas ligand against phagocytes.
    J Immunol. 1998 Nov 1;161(9):4484-8 PMID: 9794371
  27. Regulation of the proinflammatory effects of Fas ligand (CD95L).
    Science. 1998 Nov 27;282(5394):1714-7 PMID: 9831564
  28. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells.
    Immunity. 1998 Nov;9(5):711-20 PMID: 9846492
  29. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes.
    J Immunol. 1999 Jan 1;162(1):480-5 PMID: 9886423
  30. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
    Annu Rev Immunol. 1999;17:221-53 PMID: 10358758
  31. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice.
    Immunity. 1999 Sep;11(3):359-67 PMID: 10514014
  32. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand.
    Nat Med. 1998 Nov;4(11):1287-92 PMID: 9809553
  33. Serum levels of soluble Fas ligand in patients with silicosis.
    Clin Exp Immunol. 1999 Dec;118(3):441-4 PMID: 10594565
  34. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages.
    Nature. 2000 Jan 13;403(6766):199-203 PMID: 10646605
  35. Fas ligand-induced apoptosis.
    Annu Rev Genet. 1999;33:29-55 PMID: 10690403
  36. Pathology and pathophysiology of pneumoconiosis.
    Curr Opin Pulm Med. 2000 Mar;6(2):140-4 PMID: 10741774
  37. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
    J Exp Med. 2000 Apr 3;191(7):1209-20 PMID: 10748238
  38. Corpse clearance defines the meaning of cell death.
    Nature. 2000 Oct 12;407(6805):784-8 PMID: 11048729
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2001-07-16
Pages
155-64
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193452
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]